Middle East of Africa Next Generation Sequencing (NGS) Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	252 Pages	Data Bridge Market Research	April, 2024	DAABD18813154

Best Price Guarantee
Price	from $3,500
Length	252 Pages
Publisher	Data Bridge Market Research
Published Date	April, 2024
SKU	DAABD18813154

Middle East of Africa Next Generation Sequencing (NGS) Market

The Middle East and Africa next generation sequencing (NGS) market is expected to reach USD 2.80 billion by 2031 from USD 1.21 billion in 2023, growing at a CAGR of 11.7% in the forecast period of 2024 to 2031.

Market Segmentation
Middle East and Africa Next Generation Sequencing (NGS) Market, By Product & Service (Consumables, Services, and Instruments), Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Others), Application (Pharmaceuticals Microbiology, Drug & Biomarker Discovery, Diagnostics, Precision Medicine, Agricultural & Animal Research, Food Pathogen Screening, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Clinical Laboratories, Contract Research Organizations (CROS), and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and rest of Middle East and Africa) - Industry Trends and Forecast to 2031

Overview of Middle East and Africa Next Generation Sequencing (NGS) Market Dynamics
Drivers
• Increase in the adoption of genome-focused pharmacology
• Wide product portfolio offered by major players
• Use of next generation sequencing in drug development
• Increase trend towards personalized medication
Restraints
• High cost of installation and maintenance of equipment's in the laboratory
• Complexity during implementation of NGS in the clinical lab
Opportunities
• Strategic initiatives by the key market players
• Increasing advancement in NGS technology
• Increasing applications of NGS in clinical diagnostics
Challenges
• Lack of skilled professionals to perform NGS
• Data privacy and security

Market Players
The key market players operating in the Middle East and Africa next generation sequencing (NGS) market are listed below:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• QIAGEN
• Merck KGaA
• Charles River Laboratories
• Revvity
• Promega Corporation.
• Agilent Technologies, Inc.
• Takara Bio Inc.
• Eurofins Scientific
• Hamilton Company
• BGI
• Azenta US, Inc.
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• PacBio.
• Macrogen, Inc.
• Gilson Incorporated
• New England Biolabs
• Oxford Nanopore Technologies plc.
• LGC Biosearch Technologies
• PCR Biosystems
• ACT Genomics
• Quantabio
• DNASTAR
• NimaGen.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Middle East And Africa Next Generation Sequencing (Ngs) Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 DBMR Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Market Application Coverage Grid; 2.8 Product Lifeline Curve; 2.9 DBMR Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porters Five Forces
5 Market Overview: 5.1 Drivers; 5.1.1 Increase In The Adoption Of Genome-focused Pharmacology; 5.1.2 Wide Product Portfolio Offered By Major Players; 5.1.3 Use Of Next Generation Sequencing In Drug Development; 5.1.4 Increase Trend Towards Personalized Medication; 5.2 Restraints; 5.2.1 High Cost Of Installation And Maintenance Of Equipment’s In The Laboratory; 5.2.2 Complexity During Implementation Of Ngs In The Clinical Lab; 5.3 Opportunities; 5.3.1 Strategic Initiatives By The Key Market Players; 5.3.2 Increasing Advancement In Ngs Technology; 5.3.3 Increasing Applications Of Ngs In Clinical Diagnostics; 5.4 Challenges; 5.4.1 Lack Of Skilled Professionals To Perform Ngs; 5.4.2 Data Privacy And Security
6 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Product And Service: 6.1 Overview; 6.2 Consumables; 6.2.1 Library Preparation Consumables; 6.2.2 Sample Preparation Consumables; 6.3 Services; 6.3.1 Sequencing Services; 6.3.1.1 Rna Sequencing; 6.3.1.2 Dna Sequencing; 6.3.1.2.1 Whole Genome Sequencing; 6.3.1.2.2 Whole Exome Sequencing; 6.3.1.2.3 Targeted Sequencing; 6.3.1.2.4 Chip Sequencing; 6.3.1.2.5 De Novo Sequencing; 6.3.1.2.6 Others; 6.3.2 Data Management Services; 6.3.2.1 Ngs Storage, Management And Cloud Computing Solutions; 6.3.2.2 Ngs Data Analysis Software And Workbenches; 6.3.2.3 Ngs Data Analysis Services; 6.4 Instruments; 6.4.1 Benchtop; 6.4.2 Standalone; 6.4.2.1 Automated; 6.4.2.2 Semi-automated; 6.4.2.3 Manual; 6.4.2.3.1 Workstation/Platform; 6.4.2.3.2 System
7 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Technology: 7.1 Overview; 7.2 Sequencing By Synthesis (Sbs); 7.2.1 Pyrosequencing; 7.2.2 Ion Semi Conductor Sequencing; 7.2.3 Nanopore Sequencing; 7.2.4 Single-molecule-real-time Sequencing (Smrt); 7.3 Sequencing By Ligation (Sbl); 7.4 Others
8 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Application: 8.1 Overview; 8.2 Pharmaceuticals Microbiology; 8.2.1 Microbial Identification/Detection; 8.2.2 Targeted Sequencing; 8.2.3 Cell Line Characterization; 8.2.4 Antimicrobial Resistance And Predicting Antimicrobial Susceptibilities; 8.2.5 Strain Subtyping; 8.2.6 Others; 8.2.6.1 Sequencing By Synthesis (Sbs); 8.2.6.2 Sequencing By Ligation (Sbl); 8.2.6.3 Others; 8.3 Drug & Biomarker Discovery; 8.3.1 Sequencing By Synthesis (Sbs); 8.3.2 Sequencing By Ligation (Sbl); 8.3.3 Others; 8.4 Diagnostics; 8.4.1 Cancer Diagnostics; 8.4.2 Infectious Disease Diagnostics; 8.4.3 Reproductive Health Diagnostics; 8.4.4 Other Diagnostic Applications; 8.4.4.1 Sequencing By Synthesis (Sbs); 8.4.4.2 Sequencing By Ligation (Sbl); 8.4.5 Others; 8.5 Precision Medicine; 8.5.1 Sequencing By Synthesis (Sbs); 8.5.2 Sequencing By Ligation (Sbl); 8.5.3 Others; 8.6 Agricultural & Animal Research; 8.6.1 Sequencing By Synthesis (Sbs); 8.6.2 Sequencing By Ligation (Sbl); 8.6.3 Others; 8.7 Food Pathogen Screening; 8.8 Others
9 Middle East And Africa Next Generation Sequencing (Ngs) Market, By End User: 9.1 Overview; 9.2 Pharmaceutical & Biotechnology Companies; 9.3 Academic & Research Institutes; 9.4 Hospitals & Clinics; 9.5 Clinical Laboratories; 9.6 Contract Research Organizations (Cros); 9.7 Others
10 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Distribution Channel: 10.1 Overview; 10.2 Direct Tender; 10.3 Retail Sales; 10.3.1 Offline; 10.3.2 Online; 10.4 Others
11 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Region: 11.1 Middle East And Africa; 11.1.1 South Africa; 11.1.2 Saudi Arabia; 11.1.3 U.A.E.; 11.1.4 Israel; 11.1.5 Rest Of Middle East And Africa
12 Middle East And Africa Next Generation Sequencing (Ngs) Market: Company Landscape: 12.1 Company Share Analysis: Middle East And Africa
13 Swot Analysis
14 Company Profiling: 14.1 Illumina, Inc.; 14.1.1 Company Snapshot; 14.1.2 Revenueanalysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Developments; 14.2 Thermo Fisher Scientific Inc.; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Developments; 14.3 Qiagen; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Developments; 14.4 Merck Kgaa; 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Charles River Laboratories; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Developments; 14.6 Act Genomics; 14.6.1 Company Snapshot; 14.6.2 Product Portfolio; 14.6.3 Recent Developments; 14.7 Agilent Technologies, Inc.; 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Development; 14.8 Azenta Us, Inc.; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 14.8.4 Recent Development; 14.9 Beckman Coulter, Inc.; 14.9.1 Company Snapshot; 14.9.2 Product Portfolio; 14.9.3 Recent Developments; 14.10 Bio-rad Laboratories, Inc.; 14.10.1 Company Snapshot; 14.10.2 Revenue Analysis; 14.10.3 Product Portfolio; 14.10.4 Recent Developments; 14.11 Bgi (A Subsidiairy Of Bgi Group) (2024); 14.11.1 Company Snapshot; 14.11.2 Product Portfolio; 14.11.3 Recent Development; 14.12 Dnastar; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Development; 14.13 Eurofins Scientific; 14.13.1 Company Snapshot; 14.13.2 Revenue Analysis; 14.13.3 Product Portfolio; 14.13.4 Recent Developments; 14.14 Gilson Incorporated; 14.14.1 Company Snapshot; 14.14.2 Product Portfolio; 14.14.3 Recent Development; 14.15 Hamilton Company; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Development; 14.16 Lgc Biosearch Technologies; 14.16.1 Company Snapshot; 14.16.2 Product Portfolio; 14.16.3 Recent Developments; 14.17 Macrogen, Inc.; 14.17.1 Company Snapshot; 14.17.2 Revenue Analysis; 14.17.3 Product Portfolio; 14.17.4 Recent Development; 14.18 New England Biolabs; 14.18.1 Company Snapshot; 14.18.2 Product Portfolio; 14.18.3 Recent Development; 14.19 Nimagen; 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Oxford Nanopore Technologies Plc.; 14.20.1 Company Snapshot; 14.20.2 Revenue Analysis; 14.20.3 Product Portfolio; 14.20.4 Recent Developments; 14.21 Pacbio.; 14.21.1 Company Snapshot; 14.21.2 Revenue Analysis; 14.21.3 Product Portfolio; 14.21.4 Recent Developments; 14.22 Pcr Biosystems; 14.22.1 Company Snapshot; 14.22.2 Product Portfolio; 14.22.3 Recent Developments; 14.23 Promega Corporation.; 14.23.1 Company Snapshot; 14.23.2 Product Portfolio; 14.23.3 Recent Developments; 14.24 Quantabio; 14.24.1 Company Snapshot; 14.24.2 Product Portfolio; 14.24.3 Recent Development; 14.25 Revvity; 14.25.1 Company Snapshot; 14.25.2 Revenue Analysis; 14.25.3 Product Portfolio; 14.25.4 Recent Development; 14.26 Takara Bio Inc.; 14.26.1 Company Snapshot; 14.26.2 Revenue Analysis; 14.26.3 Product Portfolio; 14.26.4 Recent Developments
15 Questionnaire
16 Related Reports: Table 1 Instrument Cost Per Run; Table 2 Platform /Company Cost Per Run; Table 3 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 4 Middle East And Africa Consumables In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 5 Middle East And Africa Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 6 Middle East And Africa Services In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 7 Middle East And Africa Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 8 Middle East And Africa Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 9 Middle East And Africa Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 10 Middle East And Africa Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 11 Middle East And Africa Instruments In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 12 Middle East And Africa Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 13 Middle East And Africa Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 14 Middle East And Africa Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 15 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 16 Middle East And Africa Consumables In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 17 Middle East And Africa Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 18 Middle East And Africa Sequencing By Ligation (Sbl) In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 19 Middle East And Africa Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 20 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 21 Middle East And Africa Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 22 Middle East And Africa Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 23 Middle East And Africa Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 24 Middle East And Africa Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 25 Middle East And Africa Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 26 Middle East And Africa Diagnostics In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 27 Middle East And Africa Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 28 Middle East And Africa Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 29 Middle East And Africa Precision Medicine In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 30 Middle East And Africa Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 31 Middle East And Africa Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 32 Middle East And Africa Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 33 Middle East And Africa Food Pathogen Screening In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 34 Middle East And Africa Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 35 Middle East And Africa Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 36 Middle East And Africa Pharmaceutical & Biotechnology Companies In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 37 Middle East And Africa Academic & Research Institutes In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 38 Middle East And Africa Hospitals & Clinics In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 39 Middle East And Africa Clinical Laboratories In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 40 Middle East And Africa Contract Research Organizations (Cros) In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 41 Middle East And Africa Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 42 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 43 Middle East And Africa Direct Tender In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 44 Middle East And Africa Retail Sales In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 45 Middle East And Africa Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 46 Middle East And Africa Others In Next Generation Sequencing (Ngs) Market, By Region, 2022-2031 (Usd Million); Table 47 Middle East And Africa Next Generation Sequencing (Ngs) Market, By Country, 2022-2031 (Usd Million); Table 48 Middle East & Africa Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 49 Middle East & Africa Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 50 Middle East & Africa Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 51 Middle East & Africa Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 52 Middle East & Africa Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 53 Middle East & Africa Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 54 Middle East & Africa Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 55 Middle East & Africa Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 56 Middle East & Africa Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 57 Middle East & Africa Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 58 Middle East & Africa Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 59 Middle East & Africa Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 60 Middle East & Africa Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 61 Middle East & Africa Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 62 Middle East & Africa Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 63 Middle East & Africa Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 64 Middle East & Africa Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 65 Middle East & Africa Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 66 Middle East & Africa Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 67 Middle East & Africa Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 68 Middle East & Africa Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 69 Middle East & Africa Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 70 South Africa Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 71 South Africa Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 72 South Africa Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 73 South Africa Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 74 South Africa Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 75 South Africa Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 76 South Africa Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 77 South Africa Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 78 South Africa Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 79 South Africa Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 80 South Africa Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 81 South Africa Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 82 South Africa Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 83 South Africa Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 84 South Africa Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 85 South Africa Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 86 South Africa Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 87 South Africa Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 88 South Africa Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 89 South Africa Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 90 South Africa Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 91 South Africa Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 92 Saudi Arabia Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 93 Saudi Arabia Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 94 Saudi Arabia Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 95 Saudi Arabia Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 96 Saudi Arabia Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 97 Saudi Arabia Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 98 Saudi Arabia Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 99 Saudi Arabia Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 100 Saudi Arabia Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 101 Saudi Arabia Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 102 Saudi Arabia Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 103 Saudi Arabia Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 104 Saudi Arabia Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 105 Saudi Arabia Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 106 Saudi Arabia Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 107 Saudi Arabia Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 108 Saudi Arabia Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 109 Saudi Arabia Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 110 Saudi Arabia Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 111 Saudi Arabia Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 112 Saudi Arabia Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 113 Saudi Arabia Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 114 U.A.E. Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 115 U.A.E. Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 116 U.A.E. Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 117 U.A.E. Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 118 U.A.E. Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 119 U.A.E. Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 120 U.A.E. Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 121 U.A.E. Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 122 U.A.E. Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 123 U.A.E. Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 124 U.A.E. Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 125 U.A.E. Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 126 U.A.E. Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 127 U.A.E. Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 128 U.A.E. Drug & Biomarker Discovery In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 129 U.A.E. Diagnostics In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 130 U.A.E. Diagnostics In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 131 U.A.E. Precision Medicine In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 132 U.A.E. Agricultural & Animal Research In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 133 U.A.E. Next Generation Sequencing (Ngs) Market, By End User, 2022-2031 (Usd Million); Table 134 U.A.E. Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 135 U.A.E. Retail Sales In Next Generation Sequencing (Ngs) Market, By Distribution Channel, 2022-2031 (Usd Million); Table 136 Egypt Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 137 Egypt Consumables In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 138 Egypt Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 139 Egypt Sequencing Services In Next Generation Sequencing (Ngs) Market, By Sample, 2022-2031 (Usd Million); Table 140 Egypt Sequencing Services In Next Generation Sequencing (Ngs) Market, By Method, 2022-2031 (Usd Million); Table 141 Egypt Data Management Services In Next Generation Sequencing (Ngs) Market, By Product & Service, 2022-2031 (Usd Million); Table 142 Egypt Instruments In Next Generation Sequencing (Ngs) Market, By Modality, 2022-2031 (Usd Million); Table 143 Egypt Instruments In Next Generation Sequencing (Ngs) Market, By Mode, 2022-2031 (Usd Million); Table 144 Egypt Instruments In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 145 Egypt Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 146 Egypt Sequencing By Synthesis (Sbs) In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Table 147 Egypt Next Generation Sequencing (Ngs) Market, By Application, 2022-2031 (Usd Million); Table 148 Egypt Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Type, 2022-2031 (Usd Million); Table 149 Egypt Pharmaceuticals Microbiology In Next Generation Sequencing (Ngs) Market, By Technology, 2022-2031 (Usd Million); Figure 1 Middle East And Africa Next Generation Sequencing (Ngs) Market: Segmentation; Figure 2 Middle East And Africa Next Generation Sequencing (Ngs) Market: Data Triangulation; Figure 3 Middle East And Africa Next Generation Sequencing (Ngs) Market: Droc Analysis; Figure 4 Middle East And Africa Next Generation Sequencing (Ngs) Market: Middle East And Africa Vs Regional Market Analysis; Figure 5 Middle East And Africa Next Generation Sequencing (Ngs) Market: Company Research Analysis; Figure 6 Middle East And Africa Next Generation Sequencing (Ngs) Market: Interview Demographics; Figure 7 Middle East And Africa Next Generation Sequencing (Ngs) Market: Market Application Coverage Grid; Figure 8 Middle East And Africa Next Generation Sequencing (Ngs) Market: DBMR Market Position Grid; Figure 9 Middle East And Africa Next Generation Sequencing (Ngs) Market: Vendor Share Analysis; Figure 10 Middle East And Africa Next Generation Sequencing (Ngs) Market: Segmentation; Figure 11 Increasing Adoption Of Ngs-based Tests In Oncology, Prenatal Screening, And Infectious Disease Surveillance Is Driving The Growth Of The Middle East And Africa Next Generation Sequencing (Ngs) Market From 2024 To 2031; Figure 12 The Product And Service Segment Is Expected To Account For The Largest Share Of The Middle East And Africa Next Generation Sequencing (Ngs) Market In 2024 And 2031; Figure 13 Drivers, Restraints, Opportunities And Challenges Of Middle East And Africa Next Generation Sequencing (Ngs) Market; Figure 14 Middle East And Africa Next Generation Sequencing (Ngs) Market: By Product And Service 2023; Figure 15 Middle East And Africa Next Generation Sequencing (Ngs) Market: By Product And Services, 2024-2031 (Usd Million)